Mortality and Clostridium Difficile Infection: a Review

Overview

Journal Antimicrob Resist Infect Control

Publisher Biomed Central

Specialty Infectious Diseases

Date 2012 Sep 11

PMID 22958425

Citations 36

Authors

Brett G Mitchell

Anne Gardner

Affiliations

Soon will be listed here.

Abstract

Unlabelled:

Background: Clostridium difficile infection (CDI) is a common cause of diarrhoea in hospitalised patients. Around the world, the incidence and severity of CDI appears to be increasing, particularly in the northern hemisphere. The purpose of this integrative review was to investigate and describe mortality in hospitalised patients with CDI.

Methods: A search of the literature between 1 January 2005 and 30 April 2011 focusing on mortality and CDI in hospitalised patients was conducted using electronic databases. Papers were reviewed and analysed individually and themes were combined using integrative methods.

Results: All cause mortality at 30 days varied from 9% to 38%. Three studies report attributable mortality at 30 days, varying from 5.7% to 6.9%. In hospital mortality ranged from 8% to 37.2%

Conclusion: All cause 30 day mortality appeared to be high, with 15 studies indicating a mortality of 15% or greater. Findings support the notion that CDI is a serious infection and measures to prevent and control CDI are needed. Future studies investigating the mortality of CDI in settings outside of Europe and North America are needed. Similarly, future studies should include data on patient co-morbidities.

Citing Articles

Guidelines vs mindlines: a qualitative investigation of how clinicians' beliefs influence the application of rapid molecular diagnostics in intensive care.

Stewart S, Pandolfo A, Jani Y, Moon Z, Brealey D, Enne V Antimicrob Agents Chemother. 2025; 69(3):e0115624.

PMID: 39907301 PMC: 11881570. DOI: 10.1128/aac.01156-24.

Investigating the Effects of Nosocomial Infection Among Acute Leukemia Patients: Insights From the 2020 National Inpatient Sample.

Bodla Z, Hashmi M, Niaz F, Farooq U, Khalil M, Khalid F HCA Healthc J Med. 2025; 5(6):681-692.

PMID: 39790687 PMC: 11708941. DOI: 10.36518/2689-0216.1748.

The global burden and trend of Clostridioides difficile and its association with world antibiotic consumption, 1990-2019.

Chen Y, Xie X, Ge Q, He X, Sun Z, Li Y J Glob Health. 2024; 14:04135.

PMID: 39148479 PMC: 11327847. DOI: 10.7189/jogh.14.04135.

Mortality in clostridioides difficile infection among patients hospitalized at the university clinical hospital in Wroclaw, Poland - a 3-year observational study.

Drobnik J, Pobrotyn P, Belovicova M, Madziarska K, Trocha M, Baran M BMC Infect Dis. 2024; 24(1):625.

PMID: 38910242 PMC: 11194962. DOI: 10.1186/s12879-024-09495-7.

Antimicrobial Resistance and Associated Risk Factors for in Patients Attending Tertiary Care Settings.

Mubaraki M, Hussain M, Hassan F, Munir S, Fozia F, Ahmad I J Trop Med. 2024; 2024:6613120.

PMID: 38784112 PMC: 11115991. DOI: 10.1155/2024/6613120.

References

Kelly C, Lamont J . Clostridium difficile--more difficult than ever. N Engl J Med. 2008; 359(18):1932-40. DOI: 10.1056/NEJMra0707500. View

Labbe A, Poirier L, MacCannell D, Louie T, Savoie M, Beliveau C . Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain. Antimicrob Agents Chemother. 2008; 52(9):3180-7. PMC: 2533448. DOI: 10.1128/AAC.00146-08. View

Lyytikainen O, Turunen H, Sund R, Rasinpera M, Kononen E, Ruutu P . Hospitalizations and deaths associated with Clostridium difficile infection, Finland, 1996-2004. Emerg Infect Dis. 2009; 15(5):761-5. PMC: 2687028. DOI: 10.3201/eid1505.081154. View

Loo V, Poirier L, Miller M, Oughton M, Libman M, Michaud S . A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005; 353(23):2442-9. DOI: 10.1056/NEJMoa051639. View

McDonald L, Coignard B, Dubberke E, Song X, Horan T, Kutty P . Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol. 2007; 28(2):140-5. DOI: 10.1086/511798. View

Wilson V, Cheek L, Satta G, Walker-Bone K, Cubbon M, Citron D . Predictors of death after Clostridium difficile infection: a report on 128 strain-typed cases from a teaching hospital in the United Kingdom. Clin Infect Dis. 2010; 50(12):e77-81. DOI: 10.1086/653012. View

Cloud J, Noddin L, Pressman A, Hu M, Kelly C . Clostridium difficile strain NAP-1 is not associated with severe disease in a nonepidemic setting. Clin Gastroenterol Hepatol. 2009; 7(8):868-873.e2. DOI: 10.1016/j.cgh.2009.05.018. View

Arvand M, Hauri A, Zaiss N, Witte W, Bettge-Weller G . Clostridium difficile ribotypes 001, 017, and 027 are associated with lethal C. difficile infection in Hesse, Germany. Euro Surveill. 2009; 14(45). DOI: 10.2807/ese.14.45.19403-en. View

Heinlen L, Ballard J . Clostridium difficile infection. Am J Med Sci. 2010; 340(3):247-52. PMC: 2935936. DOI: 10.1097/MAJ.0b013e3181e939d8. View

10.

McGowan A, Lalayiannis L, Sarma J, Marshall B, Martin K, Welfare M . Thirty-day mortality of Clostridium difficile infection in a UK National Health Service Foundation Trust between 2002 and 2008. J Hosp Infect. 2010; 77(1):11-5. DOI: 10.1016/j.jhin.2010.09.017. View

11.

Cartman S, Heap J, Kuehne S, Cockayne A, Minton N . The emergence of 'hypervirulence' in Clostridium difficile. Int J Med Microbiol. 2010; 300(6):387-95. DOI: 10.1016/j.ijmm.2010.04.008. View

12.

Marra A, Edmond M, Wenzel R, Bearman G . Hospital-acquired Clostridium difficile-associated disease in the intensive care unit setting: epidemiology, clinical course and outcome. BMC Infect Dis. 2007; 7:42. PMC: 1888698. DOI: 10.1186/1471-2334-7-42. View

13.

Goorhuis A, van der Kooi T, Vaessen N, Dekker F, van den Berg R, Harmanus C . Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands. Clin Infect Dis. 2007; 45(6):695-703. DOI: 10.1086/520984. View

14.

Kenneally C, Rosini J, Skrupky L, Doherty J, Hollands J, Martinez E . Analysis of 30-day mortality for clostridium difficile-associated disease in the ICU setting. Chest. 2007; 132(2):418-24. DOI: 10.1378/chest.07-0202. View

15.

Shears P, Prtak L, Duckworth R . Hospital-based epidemiology: a strategy for 'dealing with Clostridium difficile'. J Hosp Infect. 2009; 74(4):319-25. DOI: 10.1016/j.jhin.2009.07.009. View

16.

Dubberke E, Butler A, Reske K, Agniel D, Olsen M, DAngelo G . Attributable outcomes of endemic Clostridium difficile-associated disease in nonsurgical patients. Emerg Infect Dis. 2008; 14(7):1031-8. PMC: 2600322. DOI: 10.3201/eid1407.070867. View

17.

Karas J, Enoch D, Aliyu S . A review of mortality due to Clostridium difficile infection. J Infect. 2010; 61(1):1-8. DOI: 10.1016/j.jinf.2010.03.025. View

18.

Bhangu S, Bhangu A, Nightingale P, Michael A . Mortality and risk stratification in patients with Clostridium difficile-associated diarrhoea. Colorectal Dis. 2009; 12(3):241-6. DOI: 10.1111/j.1463-1318.2009.01832.x. View

19.

Bishara J, Peled N, Pitlik S, Samra Z . Mortality of patients with antibiotic-associated diarrhoea: the impact of Clostridium difficile. J Hosp Infect. 2008; 68(4):308-14. DOI: 10.1016/j.jhin.2008.01.033. View

20.

Gasperino J, Garala M, Cohen H, Kvetan V, Currie B . Investigation of critical care unit utilization and mortality in patients infected with Clostridium difficile. J Crit Care. 2009; 25(2):282-6. DOI: 10.1016/j.jcrc.2009.04.002. View